| scholarly article | Q13442814 |
| P2093 | author name string | Jian Zhou | |
| Guowang Xu | |||
| Peng Xie | |||
| Xinyu Liu | |||
| Jian-Jun Chen | |||
| Peng Zheng | |||
| Li-Bo Zhao | |||
| Yi-Yun Liu | |||
| Xiao-Gang Zhong | |||
| Si-Wen Gui | |||
| Lan-Xiang Liu | |||
| Jun-Cai Pu | |||
| P2860 | cites work | Combined metabolomic and proteomic analysis of human atrial fibrillation | Q46780242 |
| Quantitative proteomic study of the plasma reveals acute phase response and LXR/RXR and FXR/RXR activation in the chronic unpredictable mild stress mouse model of depression | Q47426476 | ||
| The identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depression | Q47444989 | ||
| Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. | Q47841045 | ||
| Quantitative proteomics analysis of the liver reveals immune regulation and lipid metabolism dysregulation in a mouse model of depression | Q48011904 | ||
| iTRAQ-based quantitative analysis of hippocampal postsynaptic density-associated proteins in a rat chronic mild stress model of depression. | Q48085920 | ||
| Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation. | Q48658510 | ||
| Identifying blood biomarkers for mood disorders using convergent functional genomics. | Q51892229 | ||
| Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins | Q71160106 | ||
| The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis | Q21328672 | ||
| ApoE production in human monocytes and its regulation by inflammatory cytokines | Q21559536 | ||
| Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL | Q24669594 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 | Q27468570 | ||
| LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis | Q28215999 | ||
| Apolipoprotein-mediated pathways of lipid antigen presentation | Q28275773 | ||
| Aberrant apolipoprotein E expression and cognitive dysfunction in patients with poststroke depression | Q28279636 | ||
| Metadata checklist for the integrated personal OMICS study: proteomics and metabolomics experiments | Q28660029 | ||
| Universal sample preparation method for proteome analysis | Q29615662 | ||
| Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. | Q30485861 | ||
| Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats | Q33614561 | ||
| Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression | Q34084772 | ||
| An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer | Q34186593 | ||
| Large-scale gene function analysis with the PANTHER classification system | Q34358449 | ||
| Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials | Q34443846 | ||
| Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies | Q34612909 | ||
| Proteomics reveals energy and glutathione metabolic dysregulation in the prefrontal cortex of a rat model of depression | Q34751775 | ||
| Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry | Q35580090 | ||
| Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum. | Q35861541 | ||
| Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease | Q36088639 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders | Q36566937 | ||
| Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia | Q36857781 | ||
| Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV. | Q38165888 | ||
| Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases | Q38715276 | ||
| Hypoxia modulates A431 cellular pathways association to tumor radioresistance and enhanced migration revealed by comprehensive proteomic and functional studies | Q39233873 | ||
| Lysophosphatidic acid-induced proliferation-related signals in astrocytes | Q42443749 | ||
| Effect of LPS on the permeability of the blood-brain barrier to insulin | Q43558962 | ||
| Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways | Q44126345 | ||
| Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. | Q45075496 | ||
| Suicidal ideation, suicidal plan and suicidal attempts among those with major depressive disorder | Q46349121 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | major depressive disorder | Q42844 |
| metabolomics | Q12149006 | ||
| P304 | page(s) | 1451-1461 | |
| P577 | publication date | 2018-06-06 | |
| P1433 | published in | Neuropsychiatric Disease and Treatment | Q15716332 |
| P1476 | title | Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics. | |
| P478 | volume | 14 |
| Q61443153 | Altered gut metabolome contributes to depression-like behaviors in rats exposed to chronic unpredictable mild stress |
| Q64061225 | Integrated Metabolomics and Proteomics Analysis Revealed Second Messenger System Disturbance in Hippocampus of Chronic Social Defeat Stress Rat |
| Q90399488 | Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment |
Search more.